{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:45:37Z","timestamp":1787064337887,"version":"build-2736575974"},"reference-count":73,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion Medicine Reviews"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.tmrv.2019.01.001","type":"journal-article","created":{"date-parts":[[2019,1,27]],"date-time":"2019-01-27T01:06:10Z","timestamp":1548551170000},"page":"84-91","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":70,"title":["Transfusion-Transmitted Infections Reported to the National Healthcare Safety Network Hemovigilance Module"],"prefix":"10.1016","volume":"33","author":[{"given":"Kathryn A.","family":"Haass","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathew R.P.","family":"Sapiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Savinkina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5390-0465","authenticated-orcid":false,"given":"Matthew J.","family":"Kuehnert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sridhar V.","family":"Basavaraju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tmrv.2019.01.001_bb0005","doi-asserted-by":"crossref","DOI":"10.1111\/j.1537-2995.2009.02279.x","article-title":"Emerging infectious disease agents and their potential threat to transfusion safety","volume":"49","author":"Stramer","year":"2009","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2019.01.001_bb0010","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1479-5876-5-25","article-title":"Transfusion-transmitted infections","volume":"5","author":"Bihl","year":"2007","journal-title":"J Transl Med"},{"key":"10.1016\/j.tmrv.2019.01.001_bb0015","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1128\/CMR.18.1.195-204.2005","article-title":"Bacterial contamination of blood components","volume":"18","author":"Brecher","year":"2005","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.tmrv.2019.01.001_bb0020","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1001\/jama.284.2.229","article-title":"Trends in incidence and prevalence of major transfusion-transmissible viral infections in US blood donors, 1991 to 1996. Retrovirus Epidemiology Donor Study (REDS)","volume":"284","author":"Glynn","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.tmrv.2019.01.001_bb0025","first-page":"243","article-title":"US NAT yield: where are we after 2 years?","volume":"12","author":"Stramer","year":"2002","journal-title":"Beitr Infus"},{"key":"10.1016\/j.tmrv.2019.01.001_bb0030","first-page":"19","article-title":"Risk of hepatitis and retroviral infections among blood donors and introduction of nucleic acid testing (NAT)","volume":"102","author":"Dodd","year":"2000","journal-title":"Dev Biol"},{"key":"10.1016\/j.tmrv.2019.01.001_bb0035","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1046\/j.1537-2995.2002.00174.x","article-title":"Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population","volume":"42","author":"Dodd","year":"2002","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2019.01.001_bb0040","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1111\/j.1537-2995.2010.02622.x","article-title":"Prevalence, incidence, and residual risk of human immunodeficiency virus and hepatitis C virus infections among United States blood donors since the introduction of nucleic acid testing","volume":"50","author":"Zou","year":"2010","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2019.01.001_bb0045","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1111\/trf.14168","article-title":"Supplemental findings from the National Blood Collection and Utilization Surveys, 2013 and 2015","volume":"57","author":"Sapiano","year":"2017","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2019.01.001_bb0050","series-title":"Australian haemovigilance report, data for 2013-14","author":"National Blood Authority Haemovigilance Advisory Committee","year":"2015"},{"key":"10.1016\/j.tmrv.2019.01.001_bb0055","series-title":"New Zealand blood annual report 2016","author":"New Zealand Blood Service Haemovigilance Steering Group","year":"2017"},{"key":"10.1016\/j.tmrv.2019.01.001_bb0060","series-title":"Haemovigilance report of the Paul-Ehrlich-Institut 2015: assessment of the reports of serious adverse transfusion reactions pursuant to Section 63i AMG (Arzneimittelgesetz, German Medicines Act)","author":"Funk MB on behalf of the Paul-Ehrlich-Institut","year":"2017"},{"key":"10.1016\/j.tmrv.2019.01.001_bb0065","series-title":"Rapport d'activit\u00e9 h\u00e9movigilance 2016","author":"French National Agency for Medicines and Health Products Safety (ANSM)","year":"2018"},{"key":"10.1016\/j.tmrv.2019.01.001_bb0070","series-title":"TRIP report 2016 hemovigilance","author":"Foundation T","year":"2017"},{"key":"10.1016\/j.tmrv.2019.01.001_bb0075","series-title":"Haemovigilance Annual report 2016","author":"Swissmedic Swiss Agency for Therapeutic Products Safety of Medicines Department Haemovigilance Unit","year":"2017"},{"key":"10.1016\/j.tmrv.2019.01.001_bb0080","series-title":"Anticoagulation and hemostasis in neurosurgery","first-page":"139","article-title":"Risks associated with administration of allogeneic blood components","author":"DeChristopher","year":"2016"},{"key":"10.1016\/j.tmrv.2019.01.001_bb0085","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/oxfordjournals.aje.a116684","article-title":"Evaluation of a method for detecting aberrations in public health surveillance data","volume":"137","author":"Stroup","year":"1993","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.tmrv.2019.01.001_bb0090","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/S1246-7820(02)00277-X","article-title":"Bacterial contamination and transfusion safety: experience in the United States","volume":"10","author":"Dodd","year":"2003","journal-title":"Transfus Clin Biol"},{"key":"10.1016\/j.tmrv.2019.01.001_bb0095","doi-asserted-by":"crossref","first-page":"179","DOI":"10.21307\/immunohematology-2019-253","article-title":"The American Red Cross Hemovigilance Program: advancing the safety of blood donation and transfusion","volume":"25","author":"Eder","year":"2009","journal-title":"Immunohematology"},{"key":"10.1016\/j.tmrv.2019.01.001_bb0100","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1111\/trf.12980","article-title":"How is national recipient hemovigilance conducted in the United States?","volume":"55","author":"Chung","year":"2015","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2019.01.001_bb0105","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.pcl.2013.08.010","article-title":"Transfusion and hemovigilance in pediatrics","volume":"60","author":"Bolton-Maggs","year":"2013","journal-title":"Pediatr Clin North Am"},{"key":"10.1016\/j.tmrv.2019.01.001_bb0110","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/trf.13872","article-title":"Hemovigilance in Massachusetts and the adoption of statewide hospital blood bank reporting using the National Healthcare Safety Network","volume":"57","author":"Cumming","year":"2017","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2019.01.001_bb0115","series-title":"Open forum infectious diseases","first-page":"ofx175","article-title":"Antifungal susceptibility testing practices at acute care hospitals enrolled in the National Healthcare Safety Network, United States, 2011-2015","author":"Vallabhaneni","year":"2017"},{"key":"10.1016\/j.tmrv.2019.01.001_bb0120","series-title":"The National Healthcare Safety Network (NHSN) manual: biovigilance component v2.4","author":"U.S. Centers for Disease Control and Prevention","year":"2017"},{"key":"10.1016\/j.tmrv.2019.01.001_bb0125","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1046\/j.1537-2995.2001.41121493.x","article-title":"Transfusion-transmitted bacterial infection in the United States, 1998 through 2000","volume":"41","author":"Kuehnert","year":"2001","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2019.01.001_bb0130","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1423-0410.2008.01122.x","article-title":"Clinical and laboratory practices in investigation of suspected transfusion-transmitted bacterial infection: a survey of Canadian hospitals","volume":"96","author":"Traore","year":"2009","journal-title":"Vox Sang"},{"key":"10.1016\/j.tmrv.2019.01.001_bb0135","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1111\/j.1537-2995.2011.03083.x","article-title":"How do I investigate septic transfusion reactions and blood donors with culture-positive platelet donations?","volume":"51","author":"Eder","year":"2011","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2019.01.001_bb0140","article-title":"Evaluation of the national healthcare safety network hemovigilance module for transfusion-related adverse reactions in the United States","author":"Edens","year":"2018","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2019.01.001_bb0145","author":"U.S. Centers for Disease Control and Prevention. Surveillance for babesiosis\u2014United States"},{"key":"10.1016\/j.tmrv.2019.01.001_bb0150","author":"Prevention USCfDCa"},{"key":"10.1016\/j.tmrv.2019.01.001_bb0155","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1111\/trf.14202","article-title":"Residual risk of bacterial contamination of platelets: six years of experience with sterility testing","volume":"57","author":"Ramirez-Arcos","year":"2017","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2019.01.001_bb0160","series-title":"Fatalities reported to FDA following blood collection and transfusion: annual summary for fiscal year 2016","author":"U.S. Food and Drug Adminstration","year":"2016"},{"key":"10.1016\/j.tmrv.2019.01.001_bb0165","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1111\/trf.13475","article-title":"Apheresis platelets are more frequently associated with adverse reactions than pooled platelets both in recipients and in donors: a study from French hemovigilance data","volume":"56","author":"Daurat","year":"2016","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2019.01.001_bb0170","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1111\/trf.13107","article-title":"Detection of bacterial contamination in apheresis platelets: is apheresis technology a factor?","volume":"55","author":"Bravo","year":"2015","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2019.01.001_bb0175","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/jca.20043","article-title":"Blood component collection by apheresis","volume":"21","author":"Burgstaler","year":"2006","journal-title":"J Clin Apher"},{"issue":"12","key":"10.1016\/j.tmrv.2019.01.001_bb0180","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1111\/trf.14308","article-title":"Apheresis technology correlates with bacterial contamination of platelets and reported septic transfusion reactions","volume":"57","author":"Eder","year":"2017","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2019.01.001_bb0185","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1046\/j.1537-2995.1998.38998409005.x","article-title":"Evaluation of the amicus separator in the collection of apheresis platelets","volume":"38","author":"Yockey","year":"1998","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2019.01.001_bb0190","series-title":"The 2017 annual SHOT report","author":"Poles","year":"2018"},{"key":"10.1016\/j.tmrv.2019.01.001_bb0195","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1046\/j.1537-2995.2001.41070862.x","article-title":"Determinants of transfusion-associated bacterial contamination: results of the French Bacthem case-control study","volume":"41","author":"Perez","year":"2001","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2019.01.001_bb0200","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1046\/j.1537-2995.2001.41070857.x","article-title":"Single-donor platelets reduce the risk of septic platelet transfusion reactions","volume":"41","author":"Ness","year":"2001","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2019.01.001_bb0205","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1086\/529143","article-title":"Relationship between bacterial load, species virulence, and transfusion reaction with transfusion of bacterially contaminated platelets","volume":"46","author":"Jacobs","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.tmrv.2019.01.001_bb0210","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1111\/j.1537-2995.2011.03187.x","article-title":"Bacterial contamination in platelets: incremental improvements drive down but do not eliminate risk","volume":"51","author":"Jenkins","year":"2011","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2019.01.001_bb0215","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.transci.2009.10.009","article-title":"Bacterial contamination of platelets","volume":"42","author":"Palavecino","year":"2010","journal-title":"Transfus Apher"},{"key":"10.1016\/j.tmrv.2019.01.001_bb0220","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1046\/j.1423-0410.2002.00189.x","article-title":"Diversion of first blood volume results in a reduction of bacterial contamination for whole-blood collections","volume":"83","author":"De Korte","year":"2002","journal-title":"Vox Sang"},{"key":"10.1016\/j.tmrv.2019.01.001_bb0225","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1111\/j.1537-2995.2011.03308.x","article-title":"Detection of bacterial contamination in prestorage culture-negative apheresis platelets on day of issue with the Pan Genera Detection test","volume":"51","author":"Jacobs","year":"2011","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2019.01.001_bb0230","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1423-0410.2008.01051.x","article-title":"Screening platelet concentrates for bacterial contamination: low numbers of bacteria and slow growth in contaminated units mandate an alternative approach to product safety","volume":"95","author":"Murphy","year":"2008","journal-title":"Vox Sang"},{"key":"10.1016\/j.tmrv.2019.01.001_bb0235","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1423-0410.2005.00596.x","article-title":"Six years' experience of using the BacT\/ALERT system to screen all platelet concentrates, and additional testing of outdated platelet concentrates to estimate the frequency of false-negative results","volume":"88","author":"Larsen","year":"2005","journal-title":"Vox Sang"},{"key":"10.1016\/j.tmrv.2019.01.001_bb0240","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/vox.12065","article-title":"Bacterial culture of apheresis platelets: a mathematical model of the residual rate of contamination based on unconfirmed positive results","volume":"106","author":"Benjamin","year":"2014","journal-title":"Vox Sang"},{"key":"10.1016\/j.tmrv.2019.01.001_bb0245","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1111\/j.1537-2995.2008.01643.x","article-title":"A prospective observational cohort safety study of 5106 platelet transfusions with components prepared with photochemical pathogen inactivation treatment","volume":"48","author":"Osselaer","year":"2008","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2019.01.001_bb0250","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1111\/j.1537-2995.2009.02126.x","article-title":"A laboratory comparison of pathogen reduction technology treatment and culture of platelet products for addressing bacterial contamination concerns","volume":"49","author":"Goodrich","year":"2009","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2019.01.001_bb0255","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1111\/trf.14085","article-title":"Bacterial screening of platelet components by National Health Service Blood and Transplant, an effective risk reduction measure","volume":"57","author":"McDonald","year":"2017","journal-title":"Transfusion"},{"issue":"10","key":"10.1016\/j.tmrv.2019.01.001_bb0260","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1111\/trf.14198","article-title":"Improved yield of minimal proportional sample volume platelet bacterial culture","volume":"57","author":"Kamel","year":"2017","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2019.01.001_bb0265","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/j.1537-2995.2009.02460.x","article-title":"BLOOD COMPONENTS: screening of single-donor apheresis platelets for bacterial contamination: the PASSPORT study results","volume":"50","author":"Dumont","year":"2010","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2019.01.001_bb0270","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1111\/trf.14111","article-title":"Reducing the risk of septic transfusion reactions from platelets","volume":"57","author":"Tomasulo","year":"2017","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2019.01.001_bb0275","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1111\/trf.14789","article-title":"The epidemiology of bacterial culture\u2013positive and septic transfusion reactions at a large tertiary academic center: 2009 to 2016","volume":"58","author":"Erony","year":"2018","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2019.01.001_bb0280","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1111\/j.1537-2995.2008.01763.x","article-title":"Bacterial detection in apheresis platelets: blood systems experience with a two-bottle and one-bottle culture system","volume":"48","author":"Su","year":"2008","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2019.01.001_bb0285","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/j.1537-2995.2006.00746.x","article-title":"Effects of skin disinfection method, deviation bag, and bacterial screening on clinical safety of platelet transfusions in the Netherlands","volume":"46","author":"De Korte","year":"2006","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2019.01.001_bb0290","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1111\/j.1537-2995.2007.01325.x","article-title":"Investigation of an isolate of Staphylococcus lugdunensis implicated in a platelet fatality: a possible advantage of the use of an anaerobic bottle","volume":"47","author":"Brecher","year":"2007","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2019.01.001_bb0295","first-page":"65","article-title":"Bacterial contamination of platelet components not detected by BacT\/ALERT((R))","volume":"28","author":"Abela","year":"2018","journal-title":"Beitr Infus"},{"key":"10.1016\/j.tmrv.2019.01.001_bb0300","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1111\/j.1537-2995.2012.03746.x","article-title":"Transfusion-transmitted babesiosis: achieving successful mitigation while balancing cost and donor loss","volume":"52","author":"Cushing","year":"2012","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2019.01.001_bb0305","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1111\/trf.12492","article-title":"Cost-effectiveness of blood donor screening for Babesia microti in endemic regions of the United States","volume":"54","author":"Simon","year":"2014","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2019.01.001_bb0310","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1086\/595010","article-title":"Babesia infection through blood transfusions: reports received by the US Food and Drug Administration, 1997\u20132007","volume":"48","author":"Gubernot","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.tmrv.2019.01.001_bb0315","doi-asserted-by":"crossref","first-page":"509","DOI":"10.7326\/0003-4819-155-8-201110180-00362","article-title":"Transfusion-associated babesiosis in the United States: a description of cases","volume":"155","author":"Herwaldt","year":"2011","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.tmrv.2019.01.001_bb0320","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1056\/NEJMoa1600897","article-title":"Screening for Babesia microti in the U.S. blood supply","volume":"375","author":"Moritz","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tmrv.2019.01.001_bb0325","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1111\/trf.13618","article-title":"Serologic screening of United States blood donors for Babesia microti using an investigational enzyme immunoassay","volume":"56","author":"Levin","year":"2016","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2019.01.001_bb0330","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1111\/j.1537-2995.2012.03612.x","article-title":"Preventing transfusion-transmitted babesiosis: preliminary experience of the first laboratory-based blood donor screening program","volume":"52","author":"Young","year":"2012","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2019.01.001_bb0335","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1128\/CMR.00022-10","article-title":"Transfusion-transmitted Babesia spp.: bull's-eye on Babesia microti","volume":"24","author":"Leiby","year":"2011","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.tmrv.2019.01.001_bb0340","series-title":"Blood Products Advisory Committee minutes: 112th meeting","author":"U.S. Food and Drug Adminstration","year":"2015"},{"key":"10.1016\/j.tmrv.2019.01.001_bb0345","series-title":"FDA approves first tests to screen for tickborne parasite in whole blood and plasma to protect the U.S. blood supply","author":"U.S. Food and Drug Adminstration","year":"2018"},{"key":"10.1016\/j.tmrv.2019.01.001_bb0350","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/j.1537-2995.2004.04215.x","article-title":"A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors","volume":"45","author":"Busch","year":"2005","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2019.01.001_bb0355","first-page":"1335","article-title":"HIV transmission through transfusion\u2014Missouri and Colorado, 2008","volume":"59","author":"CDC","year":"2010","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.tmrv.2019.01.001_bb0360","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1111\/trf.13759","article-title":"Development of a multisystem surveillance database for transfusion-transmitted infections among blood donors in the United States","volume":"56","author":"Dodd","year":"2016","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2019.01.001_bb0365","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1182\/blood-2015-07-655944","article-title":"Detection of septic transfusion reactions to platelet transfusions by active and passive surveillance","volume":"127","author":"Hong","year":"2016","journal-title":"Blood"}],"container-title":["Transfusion Medicine Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887796318301044?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887796318301044?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:18:38Z","timestamp":1760138318000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0887796318301044"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":73,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S0887796318301044"],"URL":"https:\/\/doi.org\/10.1016\/j.tmrv.2019.01.001","relation":{},"ISSN":["0887-7963"],"issn-type":[{"value":"0887-7963","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transfusion-Transmitted Infections Reported to the National Healthcare Safety Network Hemovigilance Module","name":"articletitle","label":"Article Title"},{"value":"Transfusion Medicine Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tmrv.2019.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}